Title: 2025-2026 Regular Session HR 78 PN 0680 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0680
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 78 PN 0680 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 680 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.78 Session of 2025 INTRODUCED BY CEPEDA-FREYTIZ, BRENNAN, SANCHEZ, HILL-EVANS, SCHLOSSBERG, FREEMAN, CERRATO, HOWARD, KENYATTA, GIRAL, OTTEN, D. WILLIAMS AND GREEN, FEBRUARY 20, 2025 REFERRED TO COMMITTEE ON HUMAN SERVICES, FEBRUARY 20, 2025 A RESOLUTIONDirecting the Joint State Government Commission to establish an advisory committee and conduct a comprehensive study regarding the effectiveness of the Commonwealth's multidisciplinary approach to infants born affected by substance use or withdrawal symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder, including the success with or barriers to developing plans of safe care as required by Federal and State law.WHEREAS, For 2022, the Department of Health reported that more than 1,200 infants met the department's case definition of Neonatal Abstinence Syndrome, with more than 90% of the diagnoses linked to opioid exposure; andWHEREAS, Concerns related to parental substance use or being a substance-affected infant account for approximately 60% of all general protective service referrals involving infants; andWHEREAS, There were 424 valid concerns for children under one year old who had withdrawal symptoms or were born affected by drug exposure in 2023; andWHEREAS, State law requires medical professionals to initiate a program of safe care for an infant affected by prenatal 1234567891011121314151617181920 substance use, and 377 substance-affected infants were placed into a plan of safe care in 2023; andWHEREAS, Challenges exist in reliably tracking and reporting on outcomes for infants, including what types of services or supports are woven into a plan of safe care and how many infants are placed in foster or kinship care, referred to and tracked through early intervention or receiving services outlined with the Commonwealth's contracts with Medicaid managed care organizations; andWHEREAS, A growing number of infants with prenatal substance exposure referred to the Department of Human Services by health care professionals, as required by Federal and State law, are being classified information only, a status undefined in law, not subject to any tracking by the department and outside any measured outcomes; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to establish an advisory committee and conduct a comprehensive study regarding the effectiveness of the Commonwealth's multidisciplinary approach to infants born affected by substance use or withdrawal symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder, including the success with or barriers to developing plans of safe care as required by Federal and State law; and be it furtherRESOLVED, That the advisory committee be composed of the following:(1) The Secretary of Drug and Alcohol Programs or a designee who shall be an employee of the Department of Drug and Alcohol Programs.(2) The Secretary of Health or a designee who shall be 20250HR0078PN0680 - 2 - 123456789101112131415161718192021222324252627282930 an employee of the Department of Health.(3) The Secretary of Human Services or a designee who shall be an employee of the Department of Human Services.(4) The executive director of the Center for Rural Pennsylvania or a designee.(5) A representative from the Center for Children's Justice.(6) A member of the Behavioral Health Council.(7) A member of the Pennsylvania Perinatal Quality Collaborative.(8) A parent who has experienced receiving treatment services for substance use disorder.(9) An employee of a county Children and Youth Services.(10) Other individuals and organizations selected by the Joint State Government Commission;and be it furtherRESOLVED, That the advisory committee, in conducting the study, do all of the following:(1) Conduct a thorough review from families as to what they identify as the real or perceived challenges with plans of safe care and access to clinically appropriate substance use disorder treatment and recovery services during pregnancy and the postpartum period.(2) Evaluate feedback from interdisciplinary professionals, including stakeholders from health care, child welfare, early intervention and substance use treatment professionals regarding plans of safe care and recommendations for improved outcomes for infants and their families.(3) Develop strategies to address the existing 20250HR0078PN0680 - 3 - 123456789101112131415161718192021222324252627282930 duplication resulting from health care providers being required to make two distinct notifications, one to the Department of Health for infants meeting the Neonatal Abstinence Syndrome case definition and the other to the Department of Human Services for infants born affected by prenatal substance exposure, ensuring that any recommended new approach be grounded in public health toward limiting, as appropriate, contact with and referrals to the child welfare system.(4) Assess outcomes currently measured, including whether infants, with or without a plan of safe care in place, are being referred to and tracked as part of the Commonwealth's early intervention system, participating in evidence-based home visiting or family centers, receiving services as outlined in the Medicaid managed care contracts or discovered in other databases such as trauma registry, adoption and foster care, protective services and child death.(5) Provide projections of or actual costs related to the identification of the infants, notification to the Department of Health and the Department of Human Services about the infants and creating plans of safe care for infants, including any spending as part of Medicaid managed care organizations.(6) Identify how policy, practice, funding priorities and outcomes measured align or are in conflict across interdisciplinary local and State publicly funded agencies and to what degree the policy, practice or funding is directed to supporting infants and families within a hospital-based versus community-based setting throughout the 20250HR0078PN0680 - 4 - 123456789101112131415161718192021222324252627282930 first year of the infant's life and mother's postpartum period.(7) Document innovative strategies and successful information sharing and collaboration, including through memoranda of understanding.(8) Evaluate existing or needed State-level strategies to prevent infant and young child morbidity and mortality;and be it furtherRESOLVED, That the advisory committee issue a report of its findings to the House of Representatives no later than 18 months after the adoption of this resolution.20250HR0078PN0680 - 5 - 1234567891011


================================================================================

Raw Text:
2025-2026 Regular Session HR 78 PN 0680 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 680 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.78 Session of 2025 INTRODUCED BY CEPEDA-FREYTIZ, BRENNAN, SANCHEZ, HILL-EVANS, SCHLOSSBERG, FREEMAN, CERRATO, HOWARD, KENYATTA, GIRAL, OTTEN, D. WILLIAMS AND GREEN, FEBRUARY 20, 2025 REFERRED TO COMMITTEE ON HUMAN SERVICES, FEBRUARY 20, 2025 A RESOLUTIONDirecting the Joint State Government Commission to establish an advisory committee and conduct a comprehensive study regarding the effectiveness of the Commonwealth's multidisciplinary approach to infants born affected by substance use or withdrawal symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder, including the success with or barriers to developing plans of safe care as required by Federal and State law.WHEREAS, For 2022, the Department of Health reported that more than 1,200 infants met the department's case definition of Neonatal Abstinence Syndrome, with more than 90% of the diagnoses linked to opioid exposure; andWHEREAS, Concerns related to parental substance use or being a substance-affected infant account for approximately 60% of all general protective service referrals involving infants; andWHEREAS, There were 424 valid concerns for children under one year old who had withdrawal symptoms or were born affected by drug exposure in 2023; andWHEREAS, State law requires medical professionals to initiate a program of safe care for an infant affected by prenatal 1234567891011121314151617181920 substance use, and 377 substance-affected infants were placed into a plan of safe care in 2023; andWHEREAS, Challenges exist in reliably tracking and reporting on outcomes for infants, including what types of services or supports are woven into a plan of safe care and how many infants are placed in foster or kinship care, referred to and tracked through early intervention or receiving services outlined with the Commonwealth's contracts with Medicaid managed care organizations; andWHEREAS, A growing number of infants with prenatal substance exposure referred to the Department of Human Services by health care professionals, as required by Federal and State law, are being classified information only, a status undefined in law, not subject to any tracking by the department and outside any measured outcomes; therefore be itRESOLVED, That the House of Representatives direct the Joint State Government Commission to establish an advisory committee and conduct a comprehensive study regarding the effectiveness of the Commonwealth's multidisciplinary approach to infants born affected by substance use or withdrawal symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder, including the success with or barriers to developing plans of safe care as required by Federal and State law; and be it furtherRESOLVED, That the advisory committee be composed of the following:(1) The Secretary of Drug and Alcohol Programs or a designee who shall be an employee of the Department of Drug and Alcohol Programs.(2) The Secretary of Health or a designee who shall be 20250HR0078PN0680 - 2 - 123456789101112131415161718192021222324252627282930 an employee of the Department of Health.(3) The Secretary of Human Services or a designee who shall be an employee of the Department of Human Services.(4) The executive director of the Center for Rural Pennsylvania or a designee.(5) A representative from the Center for Children's Justice.(6) A member of the Behavioral Health Council.(7) A member of the Pennsylvania Perinatal Quality Collaborative.(8) A parent who has experienced receiving treatment services for substance use disorder.(9) An employee of a county Children and Youth Services.(10) Other individuals and organizations selected by the Joint State Government Commission;and be it furtherRESOLVED, That the advisory committee, in conducting the study, do all of the following:(1) Conduct a thorough review from families as to what they identify as the real or perceived challenges with plans of safe care and access to clinically appropriate substance use disorder treatment and recovery services during pregnancy and the postpartum period.(2) Evaluate feedback from interdisciplinary professionals, including stakeholders from health care, child welfare, early intervention and substance use treatment professionals regarding plans of safe care and recommendations for improved outcomes for infants and their families.(3) Develop strategies to address the existing 20250HR0078PN0680 - 3 - 123456789101112131415161718192021222324252627282930 duplication resulting from health care providers being required to make two distinct notifications, one to the Department of Health for infants meeting the Neonatal Abstinence Syndrome case definition and the other to the Department of Human Services for infants born affected by prenatal substance exposure, ensuring that any recommended new approach be grounded in public health toward limiting, as appropriate, contact with and referrals to the child welfare system.(4) Assess outcomes currently measured, including whether infants, with or without a plan of safe care in place, are being referred to and tracked as part of the Commonwealth's early intervention system, participating in evidence-based home visiting or family centers, receiving services as outlined in the Medicaid managed care contracts or discovered in other databases such as trauma registry, adoption and foster care, protective services and child death.(5) Provide projections of or actual costs related to the identification of the infants, notification to the Department of Health and the Department of Human Services about the infants and creating plans of safe care for infants, including any spending as part of Medicaid managed care organizations.(6) Identify how policy, practice, funding priorities and outcomes measured align or are in conflict across interdisciplinary local and State publicly funded agencies and to what degree the policy, practice or funding is directed to supporting infants and families within a hospital-based versus community-based setting throughout the 20250HR0078PN0680 - 4 - 123456789101112131415161718192021222324252627282930 first year of the infant's life and mother's postpartum period.(7) Document innovative strategies and successful information sharing and collaboration, including through memoranda of understanding.(8) Evaluate existing or needed State-level strategies to prevent infant and young child morbidity and mortality;and be it furtherRESOLVED, That the advisory committee issue a report of its findings to the House of Representatives no later than 18 months after the adoption of this resolution.20250HR0078PN0680 - 5 - 1234567891011